Literature DB >> 9044049

Transfer of phagocytosed particles to the parasitophorous vacuole of Leishmania mexicana is a transient phenomenon preceding the acquisition of annexin I by the phagosome.

H L Collins1, U E Schaible, J D Ernst, D G Russell.   

Abstract

The eukaryotic intracellular pathogen Leishmania mexicana resides inside macrophages contained within a membrane bound parasitophorous vacuole which, as it matures, acquires the characteristics of a late endosomal compartment. This study reports the selectivity of fusion of this compartment with other particle containing vacuoles. Phagosomes containing zymosan or live Listeria monocytogenes rapidly fused with L. mexicana parasitophorous vacuoles, while those containing latex beads or heat killed L. monocytogenes failed to do so. Fusigenicity of phagosomes was not primarily dependent on the receptor utilized for ingestion, as opsonization with defined ligands could not overcome the exclusion of either latex beads or heat killed organisms. However modulation of intracellular pH by pharmacological agents such as chloroquine and ammonium chloride increased delivery of live Listeria and also induced transfer of previously excluded particles. The absence of fusion correlated with the acquisition of annexin I, a putative lysosomal targeting, molecule, on the phagosome membrane. We propose that the acquisition of cellular membrane constituents such as annexin I during phagosome maturation can ultimately direct the fusion pathway of the vesicles formed and have described a model system to further document changes in vesicle fusigenicity within cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9044049     DOI: 10.1242/jcs.110.2.191

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  9 in total

1.  Impaired phagocytic mechanism in annexin 1 null macrophages.

Authors:  Simon Yona; Sigrid E M Heinsbroek; Leanne Peiser; Siamon Gordon; Mauro Perretti; Roderick J Flower
Journal:  Br J Pharmacol       Date:  2006-04-24       Impact factor: 8.739

2.  Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.

Authors:  J Morehead; I Coppens; N W Andrews
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

3.  Induction of microRNA-155 is TLR- and type IV secretion system-dependent in macrophages and inhibits DNA-damage induced apoptosis.

Authors:  Manuel Koch; Hans-Joachim Mollenkopf; Uwe Klemm; Thomas F Meyer
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-16       Impact factor: 11.205

4.  Trypanosoma cruzi Differentiates and Multiplies within Chimeric Parasitophorous Vacuoles in Macrophages Coinfected with Leishmania amazonensis.

Authors:  Carina Carraro Pessoa; Éden Ramalho Ferreira; Ethel Bayer-Santos; Michel Rabinovitch; Renato Arruda Mortara; Fernando Real
Journal:  Infect Immun       Date:  2016-04-22       Impact factor: 3.441

Review 5.  Annexin-A1: a pivotal regulator of the innate and adaptive immune systems.

Authors:  F D'Acquisto; M Perretti; R J Flower
Journal:  Br J Pharmacol       Date:  2008-07-21       Impact factor: 8.739

6.  Fusion between Leishmania amazonensis and Leishmania major parasitophorous vacuoles: live imaging of coinfected macrophages.

Authors:  Fernando Real; Renato A Mortara; Michel Rabinovitch
Journal:  PLoS Negl Trop Dis       Date:  2010-12-07

7.  The diverse and dynamic nature of Leishmania parasitophorous vacuoles studied by multidimensional imaging.

Authors:  Fernando Real; Renato A Mortara
Journal:  PLoS Negl Trop Dis       Date:  2012-02-14

Review 8.  Leishmania spp. Proteome Data Sets: A Comprehensive Resource for Vaccine Development to Target Visceral Leishmaniasis.

Authors:  Toni Aebischer
Journal:  Front Immunol       Date:  2014-06-10       Impact factor: 7.561

9.  Changes to cholesterol trafficking in macrophages by Leishmania parasites infection.

Authors:  Geo Semini; Daniel Paape; Athina Paterou; Juliane Schroeder; Martin Barrios-Llerena; Toni Aebischer
Journal:  Microbiologyopen       Date:  2017-03-27       Impact factor: 3.139

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.